These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2905690)

  • 1. Prevention of ulcer relapse: rationale.
    Dobrilla G
    Hepatogastroenterology; 1988 Dec; 35(6):295-9. PubMed ID: 2905690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer].
    Ishikawa M; Saito H; Sato J
    Nihon Rinsho; 1988 Jan; 46(1):69-78. PubMed ID: 2897486
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical relevance of tolerance to peptic ulcer healing and relapse.
    Misiewicz JJ
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():85-96. PubMed ID: 1983350
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical and surgical treatment of chronic gastric ulcer.
    Kelly KA; Malagelada JR
    Clin Gastroenterol; 1984 May; 13(2):621-34. PubMed ID: 6146418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists].
    Barner S; Waldmann D; Farthmann EH
    Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical and surgical trends in the treatment of peptic ulcer: importance of clinico-endoscopic preselection and follow-up].
    Mirelli E; De Marzo V; Siardi C; Bozzolo P
    Clin Ter; 1982 Jul; 102(1):3-13. PubMed ID: 6128097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Follow-up studies of the tissue healing process in peptic ulcer; clinicopathological study of recurrence refractory conditions in peptic ulcer].
    Saito Y; Kato T; Niwa M; Ogoshi K; Tsunoda H
    Nihon Rinsho; 1988 Jan; 46(1):94-7. PubMed ID: 2897488
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of recurrent ulceration after vagotomy for duodenal ulcer.
    Hoffmann J; Shokouh-Amiri MH
    Acta Chir Scand Suppl; 1988; 547():82-5. PubMed ID: 2906492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of stress-induced lesions of the gastrointestinal mucosa by means of drugs].
    Ditschuneit H; Malfertheiner P
    Med Welt; 1982 Jan; 33(1):78-82. PubMed ID: 6120435
    [No Abstract]   [Full Text] [Related]  

  • 11. Laparoscopic vagotomy: an operation for the 1990s?
    Penston J
    Ann R Coll Surg Engl; 1994 May; 76(3):211-2. PubMed ID: 7912490
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgery for peptic ulcer disease in children in the post-histamine2-blocker era.
    Edwards MJ; Kollenberg SJ; Brandt ML; Wesson DE; Nuchtern JG; Minifee PK; Cass DL
    J Pediatr Surg; 2005 May; 40(5):850-4. PubMed ID: 15937829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term medical prophylaxis of peptic ulcer disease].
    Rohner HG
    Dtsch Med Wochenschr; 1986 Jan; 111(3):117-8. PubMed ID: 2866944
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T; Uribe RU; Kubota T; Murakami K; Kawasaki H; Nasu M
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ulcer surgery on the cross road?].
    Christiansen J
    Ugeskr Laeger; 1989 Mar; 151(13):811. PubMed ID: 2566210
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controversies and trends in ulcer therapy. 2: Prevention of recurrence].
    Berndt H
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):743-8. PubMed ID: 7901948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changed ulcer surgery in the era of H2-blockers].
    Paimela H; Tuompo P; Peräkylä T; Saario I; Höckerstedt K; Kivilaakso E
    Duodecim; 1991; 107(6):435-40. PubMed ID: 1364891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ulcer prevention in therapy with low-dose acetylsalicylic acid?].
    Koop H
    Dtsch Med Wochenschr; 1991 Jun; 116(25):996-7. PubMed ID: 1675602
    [No Abstract]   [Full Text] [Related]  

  • 20. Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
    Marcus P; McCauley DL
    Clin Pharmacol Ther; 1997 May; 61(5):503-8. PubMed ID: 9164412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.